Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3042 | 2463 | 40.7 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
305 | 3 | NICOTINIC ACETYLCHOLINE RECEPTOR//BENZODIAZEPINES//NICOTINIC RECEPTORS | 40571 |
3042 | 2 | PERIPHERAL BENZODIAZEPINE RECEPTOR//TSPO//PK11195 | 2463 |
3595 | 1 | PERIPHERAL BENZODIAZEPINE RECEPTOR//TSPO//PK11195 | 1948 |
20454 | 1 | ACYL COA BINDING PROTEIN//DIAZEPAM BINDING INHIBITOR//ENDOZEPINES | 460 |
37521 | 1 | 3 4 AMINOPHENYL 2H CHROMEN 2 ONE//AG119//ANESTHESIOL ANAT CELL BIOL | 55 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PERIPHERAL BENZODIAZEPINE RECEPTOR | authKW | 1709680 | 7% | 81% | 171 |
2 | TSPO | authKW | 1601075 | 6% | 83% | 155 |
3 | PK11195 | authKW | 1424767 | 6% | 76% | 152 |
4 | TRANSLOCATOR PROTEIN | authKW | 735122 | 3% | 84% | 71 |
5 | DIAZEPAM BINDING INHIBITOR | authKW | 694286 | 3% | 81% | 69 |
6 | PERIPHERAL BENZODIAZEPINE RECEPTORS | authKW | 616408 | 2% | 84% | 59 |
7 | ACYL COA BINDING PROTEIN | authKW | 576532 | 2% | 76% | 61 |
8 | PERIPHERAL TYPE BENZODIAZEPINE RECEPTOR | authKW | 508421 | 3% | 63% | 65 |
9 | PBR | authKW | 492896 | 3% | 62% | 64 |
10 | TRANSLOCATOR PROTEIN 18 KDA | authKW | 416260 | 2% | 88% | 38 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 4785 | 27% | 0% | 669 |
2 | Neurosciences | 4339 | 26% | 0% | 638 |
3 | Biochemistry & Molecular Biology | 893 | 20% | 0% | 484 |
4 | Chemistry, Medicinal | 713 | 6% | 0% | 142 |
5 | Radiology, Nuclear Medicine & Medical Imaging | 690 | 8% | 0% | 189 |
6 | Endocrinology & Metabolism | 630 | 7% | 0% | 181 |
7 | Medicine, Research & Experimental | 509 | 6% | 0% | 160 |
8 | Clinical Neurology | 250 | 6% | 0% | 147 |
9 | Cell Biology | 246 | 7% | 0% | 177 |
10 | Psychiatry | 135 | 4% | 0% | 94 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | U1023 | 71413 | 0% | 52% | 11 |
2 | DISCIPLINE MED RADIAT SCI | 54066 | 1% | 16% | 27 |
3 | MOL PROBES | 51151 | 1% | 24% | 17 |
4 | RAMACIOTTI BRAIN IMAGING | 46658 | 0% | 47% | 8 |
5 | IMAGERIE MOL EXPT | 44258 | 0% | 36% | 10 |
6 | UMR 1023ERL 9218CNRSIMIV | 37187 | 0% | 100% | 3 |
7 | NEUROL IMAGING UNIT | 35721 | 0% | 41% | 7 |
8 | REG PLATFORM CELL IMAGING HAUTE NORMANDIE PRIMACE | 33053 | 0% | 67% | 4 |
9 | MOL IMAGING BRANCH | 31634 | 1% | 9% | 29 |
10 | R P ORT FAMILY MED SCI | 28640 | 1% | 7% | 35 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LIFE SCIENCES | 5303 | 4% | 0% | 94 |
2 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 4964 | 1% | 1% | 36 |
3 | EUROPEAN JOURNAL OF PHARMACOLOGY | 4188 | 4% | 0% | 99 |
4 | JOURNAL OF NUCLEAR MEDICINE | 3742 | 2% | 1% | 56 |
5 | ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY | 3497 | 0% | 2% | 12 |
6 | NUCLEAR MEDICINE AND BIOLOGY | 2594 | 1% | 1% | 28 |
7 | MOLECULAR IMAGING AND BIOLOGY | 2503 | 1% | 1% | 14 |
8 | BIOCHEMICAL PHARMACOLOGY | 1942 | 2% | 0% | 55 |
9 | CURRENT MOLECULAR MEDICINE | 1799 | 1% | 1% | 13 |
10 | NEUROPHARMACOLOGY | 1473 | 1% | 0% | 34 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PERIPHERAL BENZODIAZEPINE RECEPTOR | 1709680 | 7% | 81% | 171 | Search PERIPHERAL+BENZODIAZEPINE+RECEPTOR | Search PERIPHERAL+BENZODIAZEPINE+RECEPTOR |
2 | TSPO | 1601075 | 6% | 83% | 155 | Search TSPO | Search TSPO |
3 | PK11195 | 1424767 | 6% | 76% | 152 | Search PK11195 | Search PK11195 |
4 | TRANSLOCATOR PROTEIN | 735122 | 3% | 84% | 71 | Search TRANSLOCATOR+PROTEIN | Search TRANSLOCATOR+PROTEIN |
5 | DIAZEPAM BINDING INHIBITOR | 694286 | 3% | 81% | 69 | Search DIAZEPAM+BINDING+INHIBITOR | Search DIAZEPAM+BINDING+INHIBITOR |
6 | PERIPHERAL BENZODIAZEPINE RECEPTORS | 616408 | 2% | 84% | 59 | Search PERIPHERAL+BENZODIAZEPINE+RECEPTORS | Search PERIPHERAL+BENZODIAZEPINE+RECEPTORS |
7 | ACYL COA BINDING PROTEIN | 576532 | 2% | 76% | 61 | Search ACYL+COA+BINDING+PROTEIN | Search ACYL+COA+BINDING+PROTEIN |
8 | PERIPHERAL TYPE BENZODIAZEPINE RECEPTOR | 508421 | 3% | 63% | 65 | Search PERIPHERAL+TYPE+BENZODIAZEPINE+RECEPTOR | Search PERIPHERAL+TYPE+BENZODIAZEPINE+RECEPTOR |
9 | PBR | 492896 | 3% | 62% | 64 | Search PBR | Search PBR |
10 | TRANSLOCATOR PROTEIN 18 KDA | 416260 | 2% | 88% | 38 | Search TRANSLOCATOR+PROTEIN+18+KDA | Search TRANSLOCATOR+PROTEIN+18+KDA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GATLIFF, J , CAMPANELLA, M , (2016) TSPO: KALEIDOSCOPIC 18-KDA AMID BIOCHEMICAL PHARMACOLOGY, CONTROL AND TARGETING OF MITOCHONDRIA.BIOCHEMICAL JOURNAL. VOL. 473. ISSUE . P. 107 -121 | 143 | 82% | 8 |
2 | GAVISH, M , BACHMAN, I , SHOUKRUN, R , KATZ, Y , VEENMAN, L , WEISINGER, G , WEIZMAN, A , (1999) ENIGMA OF THE PERIPHERAL BENZODIAZEPINE RECEPTOR.PHARMACOLOGICAL REVIEWS. VOL. 51. ISSUE 4. P. 629 -650 | 197 | 86% | 332 |
3 | VEENMAN, L , GAVISH, M , (2006) THE PERIPHERAL-TYPE BENZODIAZEPINE RECEPTOR AND THE CARDIOVASCULAR SYSTEM. IMPLICATIONS FOR DRUG DEVELOPMENT.PHARMACOLOGY & THERAPEUTICS. VOL. 110. ISSUE 3. P. 503 -524 | 184 | 85% | 86 |
4 | LIU, GJ , MIDDLETON, RJ , HATTY, CR , KAM, WWY , CHAN, R , PHAM, T , HARRISON-BROWN, M , DODSON, E , VEALE, K , BANATI, RB , (2014) THE 18 KDA TRANSLOCATOR PROTEIN, MICROGLIA AND NEUROINFLAMMATION.BRAIN PATHOLOGY. VOL. 24. ISSUE 6. P. 631 -653 | 134 | 84% | 34 |
5 | CHEN, MK , GUILARTE, TR , (2008) TRANSLOCATOR PROTEIN 18 KDA (TSPO): MOLECULAR SENSOR OF BRAIN INJURY AND REPAIR.PHARMACOLOGY & THERAPEUTICS. VOL. 118. ISSUE 1. P. 1-17 | 137 | 83% | 182 |
6 | RUPPRECHT, R , PAPADOPOULOS, V , RAMMES, G , BAGHAI, TC , FAN, JJ , AKULA, N , GROYER, G , ADAMS, D , SCHUMACHER, M , (2010) TRANSLOCATOR PROTEIN (18 KDA) (TSPO) AS A THERAPEUTIC TARGET FOR NEUROLOGICAL AND PSYCHIATRIC DISORDERS.NATURE REVIEWS DRUG DISCOVERY. VOL. 9. ISSUE 12. P. 971-988 | 129 | 66% | 240 |
7 | VEENMAN, L , PAPADOPOULOS, V , GAVISH, M , (2007) CHANNEL-LIKE FUNCTIONS OF THE 18-KDA TRANSLOCATOR PROTEIN (TSPO): REGULATION OF APOPTOSIS AND STEROIDOGENESIS AS PART OF THE HOST-DEFENSE RESPONSE.CURRENT PHARMACEUTICAL DESIGN. VOL. 13. ISSUE 23. P. 2385-2405 | 161 | 75% | 105 |
8 | SCARF, AM , AUMAN, KM , KASSIOU, M , (2012) IS THERE ANY CORRELATION BETWEEN BINDING AND FUNCTIONAL EFFECTS AT THE TRANSLOCATOR PROTEIN (TSPO) (18 KDA)?.CURRENT MOLECULAR MEDICINE. VOL. 12. ISSUE 4. P. 387 -397 | 105 | 96% | 15 |
9 | KRUEGER, KE , (1995) MOLECULAR AND FUNCTIONAL PROPERTIES OF MITOCHONDRIAL BENZODIAZEPINE RECEPTORS.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON BIOMEMBRANES. VOL. 1241. ISSUE 3. P. 453-470 | 158 | 89% | 81 |
10 | KIM, T , PAE, AN , (2016) TRANSLOCATOR PROTEIN (TSPO) LIGANDS FOR THE DIAGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES: A PATENT REVIEW (2010-2015; PART 1).EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 26. ISSUE 11. P. 1325 -1351 | 101 | 86% | 0 |
Classes with closest relation at Level 2 |